Business · 27/01/2000Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for Sentinel Model 2000/2010 Patent Extension
Summary
The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the patent extension of Sentinel Model 2000/2010, a medical device, as required by law, following a submission to the US Department of Commerce.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →